Concepedia

Tomoko Terasawa

TT

Statistics

Publications

11

Citations

325

H-Index

11

Active since

2010

Affiliations

Dokkyo Medical University Saitama Medical Center(Current)

Dokkyo Medical University

Mitsubishi Chemical (Japan)

Tomoko Terasawa is an author at Dokkyo Medical University Saitama Medical Center specializing in diabetes mellitus, diabetology, and medicine.

Publications per year

2010–2020

11

Publications

11

Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea

Yoshimasa Aso, Noriyuki Ozeki, Tomoko Terasawa et al. · Translational research · 2011 · 78 citations

, , +15

Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes

Yoshimasa Aso, Kohzo Takebayashi, Sadao Wakabayashi et al. · Diabetes Research and Clinical Practice · 2010 · 41 citations

, , +14

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+ cells in patients with type 2 diabetes

Yoshimasa Aso, Teruo Jojima, Toshie Iijima et al. · Endocrine · 2015 · 34 citations

, , +12

Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes

Rika Naruse, Mariko Suetsugu, Tomoko Terasawa et al. · Saudi Medical Journal · 2013 · 33 citations · Full text

, , +17

Effect of canagliflozin on circulating active GLP-1 levels in patients with type 2 diabetes: a randomized trial

Kohzo Takebayashi, Kenji Hara, Tomoko Terasawa et al. · Endocrine Journal · 2017 · 29 citations · Full text

, , +17

1–5 of 11